Spotlight on NCI-H929
Learn more about this cell line in our scientific spotlights:
Multiple myeloma is a hematological malignancy that arises from antibody-producing plasma cells that is rarely detected prior to symptomatic disease onset. Multiple myeloma was the cause of nearly 100,000 deaths worldwide in 20181 and it is estimated that in 2021, approximately 35,000 new cases of multiple myeloma will be diagnosed and cause 12,500 deaths United States2.